CN105456563A - 一种改善肠道功能的组合物 - Google Patents

一种改善肠道功能的组合物 Download PDF

Info

Publication number
CN105456563A
CN105456563A CN201510998814.3A CN201510998814A CN105456563A CN 105456563 A CN105456563 A CN 105456563A CN 201510998814 A CN201510998814 A CN 201510998814A CN 105456563 A CN105456563 A CN 105456563A
Authority
CN
China
Prior art keywords
composition
inulin
compositions
banana powder
lactitol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201510998814.3A
Other languages
English (en)
Inventor
李金元
尚小玉
蒙仕礼
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tianjin Tiens Biological Development Co Ltd
Original Assignee
Tianjin Tiens Biological Development Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tianjin Tiens Biological Development Co Ltd filed Critical Tianjin Tiens Biological Development Co Ltd
Priority to CN201510998814.3A priority Critical patent/CN105456563A/zh
Publication of CN105456563A publication Critical patent/CN105456563A/zh
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745Bifidobacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747Lactobacilli, e.g. L. acidophilus or L. brevis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

本发明提供了一种改善肠道功能的组合物,所述组合物由乳双歧杆菌、嗜酸乳杆菌、嗜热链球菌、副干酪乳杆菌、菊粉、乳糖醇、香蕉粉和苜蓿粉组成;所述组合物中各组分协同增效,复配的菊粉和乳糖醇等更好的保持益生菌的活力,同时还添加了苜蓿提取物和香蕉粉,其中苜蓿提取物增强了组方清脾胃湿热、利大小肠、下膀胱结石的功效,香蕉粉增强了组方润肠通便的效果,全面调理胃肠道健康;所述组合物稳定性好,可直接作用于小肠具有良好的黏附性,尤其适合于东方人的体质。

Description

一种改善肠道功能的组合物
技术领域
本发明涉及一种组合物,尤其是一种改善肠道功能的组合物。
背景技术
随着生活节奏的日益加快,快餐行业垃圾食品的泛滥以及不规则的饮食习惯等,使胃肠的健康问题成为当今的社会性问题。针对这样的问题,益生菌食品被越来越多的人所认知,熟悉。现代人在饮食中摄入的益生菌的数量越来越少。许多食品和包装越来越多地使用人工合成的原材料,而且在食品中添加防腐剂、增稠剂、香精、香料等人工合成的添加剂,人们过多食用这些加工食品,极不利于体内益生菌群的生存与增殖。随着城市化、工业化的发展,环境污染越来越重,生态环境不断恶化,人类赖以生存的空气和水质量不断下降。城市饮用水往往必须经过自来水工厂的净化技术处理,尤其是经过氯处理后,含氯的饮用水会损害人体内的益生菌生长繁殖。现代人的工作生活紧张、压力增大,益生菌对人体的压力状况极为敏感。因为压力增大会改变人体内的荷尔蒙平衡,导致人体内的益生菌群数量减少。饮食中大量的精细碳水化合物和糖类会促进有害菌和酵母的生长且抑制有益细菌的繁殖。膳食中过多的肉类和过少的蔬菜水果会削弱益生菌的活性。抗生素的普及和滥用给人体会带来诸多的副作用。抗生素类药物在杀死体内有害菌的同时,也会杀死体内的有益菌。因此,专家们指出,要维护人体健康,现代人要面对这些种种不利因素,更需要经常性额外补充益生菌以改善肠道功能。
发明内容
本发明所要解决的技术问题在于提供一种改善肠道功能的组合物。
为解决上述技术问题,本发明的技术方案是:
一种改善肠道功能的组合物,由乳双歧杆菌(BifidobacteriumlactisHN019)、嗜酸乳杆菌(LactobacillusacidophilusNCFM)、嗜热链球菌(st-21)、副干酪乳杆菌(Lpc-37)、菊粉、乳糖醇、香蕉粉和苜蓿粉组成,按其重量份数计:
根据权利要求1所述的改善肠道功能的组合物,其特征在于:按其重量份数计:
优选的,上述改善肠道功能的组合物,按其重量份数计:
本发明的有益效果是:
上述改善肠道功能的组合物,各组分协同增效,复配的菊粉和乳糖醇等更好的保持益生菌的活力,同时还添加了苜蓿提取物和香蕉粉,其中苜蓿提取物增强了组方清脾胃湿热、利大小肠、下膀胱结石的功效,香蕉粉增强了组方润肠通便的效果,全面调理胃肠道健康;所述组合物稳定性(耐胃酸、耐胆汁)好,可直接作用于小肠具有良好的黏附性,尤其适合于东方人的体质。
附图说明
图1是抗生素使用期间及治疗后本发明所述组合物干预疗效图。
具体实施方式
下面结合具体实施例对本发明所述技术方案作进一步的说明。
其中,所采用的益生菌选用丹尼斯克公司的菌种。
实施例1
一种改善肠道功能的组合物,由乳双歧杆菌(BifidobacteriumlactisHN019)、嗜酸乳杆菌(LactobacillusacidophilusNCFM)、嗜热链球菌(st-21)、副干酪乳杆菌(Lpc-37)、菊粉、乳糖醇、香蕉粉和苜蓿粉组成,具体用量见表1,所述组合物是由下述方法获得的:
(1)按组方量称取乳双歧杆菌(BifidobacteriumlactisHN019)、嗜酸乳杆菌(LactobacillusacidophilusNCFM)、嗜热链球菌(st-21)、副干酪乳杆菌(Lpc-37)、菊粉、乳糖醇、香蕉粉和苜蓿粉为原料;
(2)将各组分混合均匀,即得。
表1
实施例2
实施例1-1所述改善肠道功能的组合物的功效实验
研究对象:40名成年患者,平均年龄37.2岁。
试验设计:随机、双盲、对照试验研究,共持续48天。第1、7、14天时,采集试验者粪便样本,自第14天起,患者口服阿莫西林克拉维酸钾(GSK生产)875mg,每日两次,连服七天。在第21、25、34、48天时继续采集粪便标本。实验组和对照组干预时间为第14天至34天。
试验分组:实验组,20人:空腹口服实施例1-1所述组合物,每日两次,每次2g。
对照组,20人:空腹口服安慰剂(麦芽糊精),每日两次,每次2g。
评价指标:通过对粪便中微生物的评估检测生物标记物,进而评估抗生素使用期间及治疗后本发明所述组合物干预的疗效,结果见图1。
由图1可以看出,抗生素治疗后两周,实验组患者肠道内总菌群数量仍保持至治疗前水平,本发明所述组合物可帮助机体在抗生素治疗期间,快速重建肠道内微生态环境,改善肠道功能。
上述参照实施例对该一种改善肠道功能的组合物进行的详细描述,是说明性的而不是限定性的,可按照所限定范围列举出若干个实施例,因此在不脱离本发明总体构思下的变化和修改,应属本发明的保护范围之内。

Claims (3)

1.一种改善肠道功能的组合物,其特征在于:由乳双歧杆菌、嗜酸乳杆菌、嗜热链球菌、副干酪乳杆菌、菊粉、乳糖醇、香蕉粉和苜蓿粉组成,按其重量份数计:
2.根据权利要求1所述的改善肠道功能的组合物,其特征在于:按其重量份数计:
3.根据权利要求1所述的改善肠道功能的组合物,其特征在于:按其重量份数计:
CN201510998814.3A 2015-12-25 2015-12-25 一种改善肠道功能的组合物 Pending CN105456563A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510998814.3A CN105456563A (zh) 2015-12-25 2015-12-25 一种改善肠道功能的组合物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510998814.3A CN105456563A (zh) 2015-12-25 2015-12-25 一种改善肠道功能的组合物

Publications (1)

Publication Number Publication Date
CN105456563A true CN105456563A (zh) 2016-04-06

Family

ID=55595020

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510998814.3A Pending CN105456563A (zh) 2015-12-25 2015-12-25 一种改善肠道功能的组合物

Country Status (1)

Country Link
CN (1) CN105456563A (zh)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105901548A (zh) * 2016-04-12 2016-08-31 河南农业大学 一种苜蓿火腿肠的制备方法
CN106072657A (zh) * 2016-06-08 2016-11-09 天津隆顺榕发展制药有限公司 益生菌组合物及其制备方法
CN109198646A (zh) * 2018-10-29 2019-01-15 广州普维君健药业有限公司 具有防治肠道炎症性疾病功效的益生菌组合物及其应用
CN113197311A (zh) * 2020-07-03 2021-08-03 内蒙古蒙牛乳业(集团)股份有限公司 一种乳酸菌组合物及其制备方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102438589A (zh) * 2009-03-09 2012-05-02 益生菌股份公司 用于儿科应用的含益生菌的油性悬浮液
CN102470152A (zh) * 2009-07-30 2012-05-23 丹尼斯科公司 用于治疗内毒素血症的乳酸菌和双歧杆菌
CN105124333A (zh) * 2015-09-02 2015-12-09 曹博雅 一种含益生菌组合物及其制备方法和应用

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102438589A (zh) * 2009-03-09 2012-05-02 益生菌股份公司 用于儿科应用的含益生菌的油性悬浮液
CN102470152A (zh) * 2009-07-30 2012-05-23 丹尼斯科公司 用于治疗内毒素血症的乳酸菌和双歧杆菌
CN105124333A (zh) * 2015-09-02 2015-12-09 曹博雅 一种含益生菌组合物及其制备方法和应用

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105901548A (zh) * 2016-04-12 2016-08-31 河南农业大学 一种苜蓿火腿肠的制备方法
CN106072657A (zh) * 2016-06-08 2016-11-09 天津隆顺榕发展制药有限公司 益生菌组合物及其制备方法
CN109198646A (zh) * 2018-10-29 2019-01-15 广州普维君健药业有限公司 具有防治肠道炎症性疾病功效的益生菌组合物及其应用
CN113197311A (zh) * 2020-07-03 2021-08-03 内蒙古蒙牛乳业(集团)股份有限公司 一种乳酸菌组合物及其制备方法

Similar Documents

Publication Publication Date Title
Syngai et al. Probiotics-the versatile functional food ingredients
Timmerman et al. Monostrain, multistrain and multispecies probiotics—A comparison of functionality and efficacy
Liu et al. Effects of Lactobacillus brevis preparation on growth performance, fecal microflora and serum profile in weaned pigs
CA2787544C (en) Probiotic composition for use in the treatment of bowel inflammation
EP2990045B1 (en) Bifidobacterium animalis subsp. lactis for use in decreasing abdominal pain in a postmenopausal woman
CN105985918B (zh) 抗肥胖的乳酸菌菌株及其在食品组成物以及医药组成物中的应用
CN105456563A (zh) 一种改善肠道功能的组合物
CA2893822C (en) Strain of bifidobacterium animalis ssp. animalis
CN107691955A (zh) 益生菌固体饮料及其制备方法
CN111972670A (zh) 一种润肠通便的组合物、固体饮料及应用
CN107308190A (zh) 调节人体微生态平衡的益生菌组合物及其培养物、制剂、用途
CN103637219A (zh) 益生菌组合物及其应用、婴幼儿食品
El-Ezabi et al. The viability of probiotics as a factor influencing the immune response in the Nile tilapia, Oreochromis niloticus
JP6290080B2 (ja) 新規乳酸菌
CN108576823A (zh) 一种抗氧化、抗衰老的合生元组合物及其制剂与应用
WO2020074547A1 (en) Lactobacillus crispatus probiotic strains suitable for treating urogenital yeast and bacterial infections
Wang et al. Assessment of probiotic properties of Lactobacillus plantarum ZLP001 isolated from gastrointestinal tract of weaning pigs
CN106727725A (zh) 一种治疗肠道菌群紊乱的益生菌肠溶胶囊及其囊体
CN110432494A (zh) 防治婴幼儿过敏性湿疹和/或腹泻的益生菌组合物和应用
EP2220210B1 (en) Strains of lactobacillus plantarum as probiotics with immunomodulatory specific effect
CN113197311B (zh) 一种乳酸菌组合物及其制备方法
CN111602761A (zh) 一种缓解或治疗肠易激综合症的益生菌固体饮料
Gupta et al. Selection criteria for probiotics and potential of cereal based food products as novel probiotic-carriers
CN109645501A (zh) 一种通便和减少胀气的低聚半乳糖组合物及其应用
CN103918793B (zh) 一种健胃消食益生菌羊奶片及其制备方法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20160406